Explore Topics:
AIBiotechnologyRoboticsComputingFutureScienceSpaceEnergyTech
Biotechnology

FDA Approves Artificial Pancreas You Can Wear

The Food and Drug Administration recently issued its first-ever approval of an artificial pancreas that may make life easier and healthier for such patients. The device, made by Minneapolis-based Medtronics, relies on a computer algorithm to sync the results of a continuous reading of the wearer’s glucose levels and with a pump that provides appropriate amounts of insulin.

Cameron Scott
Sep 28, 2013

Share

medtronic-artificial-pancreas-banner


Diabetes has reached epidemic proportions in the United States and many other countries around the world. And unlike the more common acquired form of diabetes, the Type 1 form of the illness has neither prevention nor cure. Sufferers simply don’t produce insulin, the hormone excreted by the pancreas to process glucose in the body. Patients are stuck monitoring their blood sugar levels with pinpricks and injecting themselves with synthetic insulin.

The Food and Drug Administration recently issued its first-ever approval of an artificial pancreas that may make life easier and healthier for such patients. The device, made by Minneapolis-based Medtronics, relies on a computer algorithm to sync the results of a continuous reading of the wearer’s glucose levels with a pump that provides appropriate amounts of insulin.

Diabetics can currently get continuous glucose monitoring devices and insulin pumps, but the two are not connected.

artificial-pancreas-torso

“This is a significant step towards an artificial pancreas device system,” FDA press officer Jenny Haliski told Singularity Hub.

Although the Medtronics device is called an artificial pancreas, it looks more like pager, which hooks over to the belt and attaches to a sensor that patients insert under the skin.

Its advantage is that it can automatically shut off the supply of insulin if the wearer’s glucose levels fall too low, which can lead to a diabetic coma. The device first alerts the wearer if blood sugar becomes dangerously low, but if s/he doesn’t respond, it shuts off the insulin supply for two hours. The sensor is also billed as more accurate, though still not as accurate as one might hope: Its false alarm rate is 33 percent, according to Medtronics.

Still, the connected monitor and pump setup has been some time in the making and may be the best way to treat diabetes in the absence of a  breakthrough.

artificial-pancreas-device

Be Part of the Future

Sign up to receive top stories about groundbreaking technologies and visionary thinkers from SingularityHub.

100% Free. No Spam. Unsubscribe any time.

For patients it offers real improvements in quality of life.

“Wow, this is amazing. It says a couple of weeks from now it will be available. Wow! This is huge. No competitor is anywhere near this,” said Ami Eaton, a San Franciscan in her 30s who suffers from Type 1 diabetes. She uses a Medtron insulin pump, which allows her to set how much insulin to provide based on manual blood sugar readings.

Eaton explained that, for fear of passing out, she sometimes gives herself only a conservative amount of insulin, which at times leaves her blood sugar levels higher than her doctor would like.

Medtronic says it will begin selling the device, called the MiniMed 530G, in the next few weeks.

The company hopes its next model will be a "fully automated artificial pancreas" that requires almost no input from the wearer.

Images: Medtronic MiniMed courtesy Medtronic; chart via FDA

Cameron received degrees in Comparative Literature from Princeton and Cornell universities. He has worked at Mother Jones, SFGate and IDG News Service and been published in California Lawyer and SF Weekly. He lives, predictably, in SF.

Related Articles

Mitochondria (gold) surrounding cell nuclei (blue) in cow cells.

Scientists Target Incurable Mitochondrial Diseases With New Gene Editing Tools

Shelly Fan
Mice climb on a plant.

Mice With Two Dads Reach Adulthood Thanks to CRISPR

Shelly Fan
Digital representation of embryos undergoing mitosis.

CRISPR Baby 2.0? Controversial Simulation Touts Benefits of Gene Editing Embryos

Shelly Fan
Mitochondria (gold) surrounding cell nuclei (blue) in cow cells.
Biotechnology

Scientists Target Incurable Mitochondrial Diseases With New Gene Editing Tools

Shelly Fan
Mice climb on a plant.
Biotechnology

Mice With Two Dads Reach Adulthood Thanks to CRISPR

Shelly Fan
Digital representation of embryos undergoing mitosis.
Biotechnology

CRISPR Baby 2.0? Controversial Simulation Touts Benefits of Gene Editing Embryos

Shelly Fan

What we’re reading

Be Part of the Future

Sign up to receive top stories about groundbreaking technologies and visionary thinkers from SingularityHub.

100% Free. No Spam. Unsubscribe any time.

SingularityHub chronicles the technological frontier with coverage of the breakthroughs, players, and issues shaping the future.

Follow Us On Social

About

  • About Hub
  • About Singularity

Get in Touch

  • Contact Us
  • Pitch Us
  • Brand Partnerships

Legal

  • Privacy Policy
  • Terms of Use
© 2025 Singularity